VASOGENIX PHARMACEUTICALS INC has a total of 14 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are SYNCHRONEURON LLC, CHOWHAN MASOOD A and GLAXO CANADA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Southard Jeffrey L | 13 |
#2 | Southard George Lee | 10 |
#3 | Yewey Gerald L | 3 |
#4 | Rosenthal Gary J | 3 |
#5 | Southard Jeffrey Lee | 1 |
#6 | Southard George L | 1 |
Publication | Filing date | Title |
---|---|---|
US2011150980A1 | Cgrp analog | |
CA2552677A1 | Controlled release cgrp delivery composition for cardiovascular and renal indications | |
EP1703916A2 | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same | |
WO2005070444A2 | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same | |
US6809079B2 | Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide |